{"answers":{"affected":"It affects 1 product.","exploited":"There is no known exploitation of CVE-2023-22868 in the wild and no public exploit code.","fix":"No fix has been published for CVE-2023-22868 yet. Limit exposure of the affected software until one is available.","what":"CVE-2023-22868 is a medium-severity cross-site scripting vulnerability in IBM Aspera Faspex, published on 17 Feb 2023. Any signed-in user can exploit it over the network, and only if a user opens a file or follows a link."},"fix_prompt":"Check this codebase for CVE-2023-22868 and fix it if it is affected.\n\nWhat it is: CVE-2023-22868 is a medium-severity cross-site scripting vulnerability in IBM Aspera Faspex, published on 17 Feb 2023. Any signed-in user can exploit it over the network, and only if a user opens a file or follows a link.\nExploitation: There is no known exploitation of CVE-2023-22868 in the wild and no public exploit code.\n\nAffected product: IBM Aspera Faspex. No package-level version data is available, so check the vendor advisory linked from the reference page.\n\nTask:\n1. Search the dependency manifests and lockfiles (for example package.json, package-lock.json, requirements.txt, poetry.lock, uv.lock, pom.xml, build.gradle, go.mod, Cargo.lock, Gemfile.lock) and any Dockerfiles for the affected packages, including transitive dependencies.\n2. If an affected version is in use, upgrade it to the fixed version for its release line with the project's package manager, so the lockfile is regenerated. Prefer the smallest upgrade that fixes it.\n3. If there is no fix, or the upgrade would break the build, do not guess: explain the risk and the safest workaround instead.\n4. Run the tests and summarise what changed and why.\n5. If nothing in the project is affected, say so and change nothing.\n\nReference: https://insights.sbomify.com/CVE-2023-22868/ (Markdown: https://insights.sbomify.com/CVE-2023-22868/index.md)","id":"CVE-2023-22868","markdown":"https://insights.sbomify.com/CVE-2023-22868/index.md","name":"CVE-2023-22868","record":{"aliases":["GHSA-jp4v-7j7r-jrc5"],"analysis":{"component_type":"web_application","fix_type":"patch","impacts":["data_read","account_takeover"],"network_reachable":"yes","non_default_config":false,"product_category":"IBM Aspera Faspex","requires_auth":"low_privilege","summary":"Attackers can inject JavaScript into the IBM Aspera Faspex web interface to steal credentials or alter functionality within trusted sessions.","user_interaction":"required","vuln_class":"xss"},"analysis_generated_by":"qwen3.8-flash-next","assigner":"ibm","cpe":[{"product":"aspera_faspex","vendor":"ibm"}],"cvss":{"score":5.4,"severity":"medium","source":"cna","vector":"CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N","version":"3.1"},"cwes":[{"id":"CWE-79","name":"Improper Neutralization of Input During Web Page Generation"}],"description":"IBM Aspera Faspex 4.4.1 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.  IBM X-Force ID:  244117.","ecosystems":[],"exploits":{"exploitdb":0,"first_seen":null,"github_poc":0,"max_poc_stars":null,"metasploit":0,"nuclei":0,"refs":[],"tier":"none_known"},"has_fix":null,"headline":"IBM Aspera Faspex cross-site scripting","id":"CVE-2023-22868","indexable":true,"kev":null,"kind":"cve","links":{"ecosystem":null,"product":null,"products":[],"type":"xss","year":"2023"},"n_packages":0,"n_references":2,"next":{"headline":"IBM Aspera Faspex information disclosure","id":"CVE-2023-22869"},"packages":[],"prev":{"headline":"IBM Robotic Process Automation information disclosure","id":"CVE-2023-22863"},"products":["Aspera Faspex"],"published":"2023-02-17","related":[{"cvss_score":9.8,"headline":"IBM Aspera Faspex Code Execution","id":"CVE-2022-47986","kev_date_added":"2023-02-21","published":"2023-02-17"},{"cvss_score":9.9,"headline":"IBM Aspera Faspex XML external entity injection","id":"CVE-2023-27874","kev_date_added":null,"published":"2023-03-21"},{"cvss_score":9.1,"headline":"OS command injection in IBM Aspera Faspex","id":"CVE-2026-14958","kev_date_added":null,"published":"2026-07-28"},{"cvss_score":9.1,"headline":"OS Command Injection in IBM Aspera Faspex","id":"CVE-2026-14959","kev_date_added":null,"published":"2026-07-28"},{"cvss_score":8.2,"headline":"Multiple vulnerabilities in IBM Aspera Faspex","id":"CVE-2026-14996","kev_date_added":null,"published":"2026-07-28"},{"cvss_score":7.8,"headline":"IBM Aspera Faspex privilege escalation","id":"CVE-2023-37400","kev_date_added":null,"published":"2024-04-19"},{"cvss_score":7.5,"headline":"IBM Aspera Faspex improper access control","id":"CVE-2023-30995","kev_date_added":null,"published":"2023-09-08"}],"sources":[{"class":"attribution","licence":"CVE Terms of Use (MITRE)","name":"CVE List","prefix":"CVE"},{"class":"attribution","licence":"US public information, NVD API terms","name":"NVD"},{"class":"attribution","licence":"CWE Terms of Use","name":"CWE (MITRE)"},{"class":"attribution","licence":"FIRST CVSS licence","name":"CVSS (FIRST)"}],"ssvc":{"automatable":"no","exploitation":"none","technical_impact":"partial"},"state":"PUBLISHED","updated":"2025-03-12","vendors":["IBM"]},"summary":"Attackers can inject JavaScript into the IBM Aspera Faspex web interface to steal credentials or alter functionality within trusted sessions.","url":"https://insights.sbomify.com/CVE-2023-22868/"}